Frontiers Health is excited to announce that Finnish pharmaceutical company Orion will be joining the 2021 conference as a partner. As a globally operating builder of well-being. Orion develops, manufactures, and markets human and veterinary pharmaceuticals.

The company is continuously cultivating new active ingredients, drugs, and treatment methods, including digital therapies. Orion’s core R&D therapy areas are neurological disorders, oncology and respiratory diseases, for which Orion develops inhaled pulmonary medication. Orion’s net sales in 2020 amounted to EUR 1,078 million and the company had about 3,300 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.

Join us to learn more about Orion.